The von hippel-lindau tumor suppressor protein: an update

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• The von Hippel-Lindau (VHL) tumor suppressor gene is frequently inactivated in various cancers, including clear cell renal carcinoma and pheochromocytoma.
• The best-characterized function of the VHL protein (pVHL) is its role in targeting the hypoxia-inducible transcription factor (HIF) for degradation.
• Dysregulation of pVHL is implicated in tumorigenesis and cellular processes.

Purpose of the Study:

• To review recent research (past 2 years) on the VHL protein (pVHL).
• To investigate the in vivo and in vitro functions of pVHL, particularly its relationship with HIF.
• To explore novel roles of pVHL beyond HIF regulation.

Main Methods:

• Analysis of studies using genetically engineered mouse models to study pVHL and HIF interactions in vivo.
• Review of cell culture studies examining pVHL's role in epithelial differentiation and primary cilium maintenance.
• Examination of recent findings on HIF-independent functions of pVHL.

Main Results:

• Genetically engineered mice studies confirm the in vivo link between pVHL and HIF.
• Cell culture data highlight pVHL's importance in epithelial differentiation and primary cilium function.
• Emerging evidence suggests pVHL regulates neuronal apoptosis independently of HIF, impacting pheochromocytoma risk.

Conclusions:

• pVHL plays a critical role in cellular processes, including HIF regulation, epithelial differentiation, and primary cilium maintenance.
• Recent research reveals HIF-independent functions of pVHL in neuronal apoptosis, linking it to pheochromocytoma development.
• Continued investigation into pVHL functions is crucial for understanding VHL-associated tumorigenesis.